Investigation of a Suspect Severe Acute Respiratory Syndrome Coronavirus-2 and Influenza A Mixed Outbreak: Lessons Learned for Long-Term Care Facilities Nationwide.

COVID-19 Disease Outbreaks Humans Influenza, Human / diagnosis Long-Term Care SARS-CoV-2
COVID-19 SARS-CoV-2 influenza long-term care facility outbreak

Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
15 07 2021
Historique:
pubmed: 7 5 2021
medline: 21 7 2021
entrez: 6 5 2021
Statut: ppublish

Résumé

A suspected outbreak of influenza A and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at a long-term care facility in Los Angeles County was, months later, determined to not involve influenza. To prevent inadvertent transmission of infections, facilities should use highly specific influenza diagnostics and follow Centers for Disease Control and Prevention (CDC) guidelines that specifically address infection control challenges.

Identifiants

DOI: 10.1093/cid/ciab372 PMID: 33956136 PMC: PMC8135935
pubmed: 33956136
pii: 6270741
doi: 10.1093/cid/ciab372
pmc: PMC8135935
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

S77-S80

Subventions

Organisme : Infectious Diseases Society of America through Cooperative Agreement
ID : NU50CK000574

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Published by Oxford University Press for the Infectious Diseases Society of America 2021.

Auteurs

Caroline A Schrodt (CA)

Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
CDC COVID-19 Response Team, Atlanta, Georgia, USA.

Jason H Malenfant (JH)

Acute Communicable Disease Control Program, Los Angeles County Department of Public Health, Los Angeles, California, USA.

Jennifer C Hunter (JC)

Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Kara Jacobs Slifka (KJ)

Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Angela Campbell (A)

Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Nimalie Stone (N)

Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Erin R Whitehouse (ER)

Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
CDC COVID-19 Response Team, Atlanta, Georgia, USA.

Beth Wittry (B)

CDC COVID-19 Response Team, Atlanta, Georgia, USA.

Bryan Christensen (B)

CDC COVID-19 Response Team, Atlanta, Georgia, USA.

John R Barnes (JR)

Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Lynnette Brammer (L)

Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Peera Hemarajata (P)

Public Health Laboratory, Los Angeles County Department of Public Health, Downey, California, USA.

Nicole M Green (NM)

Public Health Laboratory, Los Angeles County Department of Public Health, Downey, California, USA.

Rachel Civen (R)

Community Health Services Program, Los Angeles County Department of Public Health, Los Angeles, California, USA.

Prabhu P Gounder (PP)

Acute Communicable Disease Control Program, Los Angeles County Department of Public Health, Los Angeles, California, USA.

Agam K Rao (AK)

CDC COVID-19 Response Team, Atlanta, Georgia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID-19 › Investigation of a Suspect Severe Acute...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Épidémies de maladies › Investigation of a Suspect Severe Acute...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Investigation of a Suspect Severe Acute...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Grippe humaine › Investigation of a Suspect Severe Acute...
questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Services de santé › Soins aux patients › Soins de longue durée › Investigation of a Suspect Severe Acute...
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › Virus du SRAS › SARS-CoV-2 › Investigation of a Suspect Severe Acute...